Abstract
FIV is a significant pathogen in the cat and is, in addition, the smallest available natural model for the study of lentivirus infections. Although divergent at the amino acid level, the cat lentivirus has an abundance of structural and pathophysiological commonalities with HIV and thus serves well as a model for development of intervention strategies relevant to infection in both cats and man. The following review highlights both the strengths and shortcomings of the FIV/cat model, particular as regards development of antiviral drugs.
Current HIV Research
Title: Feline Immunodeficiency Virus (FIV) as A Model for Study of Lentivirus Infections: Parallels with HIV
Volume: 8 Issue: 1
Author(s): John H. Elder, Ying-Chuan Lin, Elizabeth Fink and Chris K. Grant
Affiliation:
Abstract: FIV is a significant pathogen in the cat and is, in addition, the smallest available natural model for the study of lentivirus infections. Although divergent at the amino acid level, the cat lentivirus has an abundance of structural and pathophysiological commonalities with HIV and thus serves well as a model for development of intervention strategies relevant to infection in both cats and man. The following review highlights both the strengths and shortcomings of the FIV/cat model, particular as regards development of antiviral drugs.
Export Options
About this article
Cite this article as:
Elder H. John, Lin Ying-Chuan, Fink Elizabeth and Grant K. Chris, Feline Immunodeficiency Virus (FIV) as A Model for Study of Lentivirus Infections: Parallels with HIV, Current HIV Research 2010; 8 (1) . https://dx.doi.org/10.2174/157016210790416389
DOI https://dx.doi.org/10.2174/157016210790416389 |
Print ISSN 1570-162X |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4251 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Serotonergic and Cholinergic Strategies as Potential Targets for the Treatment of Schizophrenia
Current Pharmaceutical Design Tactile Angle Discrimination Decreases due to Subjective Cognitive Decline in Alzheimer’s Disease
Current Alzheimer Research Aminoglycoside-Induced Ototoxicity
Current Pharmaceutical Design The Anterior-posterior Functional Connectivity Disconnection in the Elderly with Subjective Memory Impairment and Amnestic Mild Cognitive Impairment
Current Alzheimer Research Senescence of the Brain: Focus on Cognitive Kinases
Current Pharmaceutical Design Sex, Stress and their Influence on Respiratory Regulation
Current Pharmaceutical Design Advances in Drug Safety
Current Pharmaceutical Design Synthetic Cathinones: A New Public Health Problem
Current Neuropharmacology Cannabis and Cognitive Systems in Adolescents
Adolescent Psychiatry The Role of Therapeutic Drugs on Acquired Mitochondrial Toxicity
Current Drug Metabolism cGMP Signaling, Phosphodiesterases and Major Depressive Disorder
Current Neuropharmacology Leber's Hereditary Optic Neuropathy: Novel Views and Persisting Challenges
CNS & Neurological Disorders - Drug Targets Stress, Depression and Antidepressant Treatment Options in Patients Suffering from Multiple Sclerosis
Current Pharmaceutical Design Histamine H<sub>4</sub> Receptor Antagonists: A New Approach for Tinnitus Treatment?
Recent Patents on CNS Drug Discovery (Discontinued) Cell and Gene-Based Therapies for the Lysosomal Storage Diseases
Current Gene Therapy Disorders of Consciousness and Pharmaceuticals that Act on Oxygen Based Amino Acid and Monoamine Neurotransmitter Pathways of the Brain
Current Pharmaceutical Design Stimulating Effects of H1-Antagonists
Current Pharmaceutical Design Treating Schizophrenia: Novel Targets for the Cholinergic System
CNS & Neurological Disorders - Drug Targets Histamine H3-Receptor Inverse Agonists as Novel Antipsychotics
Central Nervous System Agents in Medicinal Chemistry Serotonin 5-HT<sub>1A</sub> Receptors and Antipsychotics - An Update in Light of New Concepts and Drugs
Current Pharmaceutical Design